Retraction Note: Release-Active Dilutions of Diclofenac Enhance Anti-inflammatory Effect of Diclofenac in Carrageenan-Induced Rat Paw Edema Model (Inflammation, (2014), 37, 1, (1-9), 10.1007/s10753-013-9705-0);Release-active dilutions of diclofenac enhance anti-inflammatory effect of diclofenac in carrageenan-induced rat paw edema model

Inflammation

Volumn 37, Issue 1, 2014, Pages 1-9

  Sakat, Sachin S ^a   Mani, Kamaraj ^a   Demidchenko, Yulia O ^b   Gorbunov, Evgeniy A ^b   Tarasov, Sergey A ^b   Mathur, Archna ^a   Epstein, Oleg I ^b  

^a DABUR RESEARCH FOUNDATION   (India)

^b OOO NPF Materia Medica Holding   (Russian Federation)

Author keywords

anti inflammatory; carrageenan; diclofenac; edema

Indexed keywords

CARRAGEENAN; DICLOFENAC; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DILUTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; DRUG SOLUTION; LOW DRUG DOSE; MALE; NONHUMAN; PAW EDEMA; RAT; RAT MODEL; RELEASE ACTIVE DILUTION; WISTAR ALBINO GLAXO RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; EDEMA; FOOT; INFLAMMATION; MALE; RATS; RATS, WISTAR;

EID: 84900364727     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-020-01359-x     Document Type: Erratum

References (40)

1. Burke, A., Smyth, E., Garret, A., FitzGerald. 2006. In: Laurence, L.B, John, S.L., Keith, L.P. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics.11th Edn. pp. 698. McGraw Hill: New York
2. al-Tuwaijri, A.S., and A.A. Mustafa. 1992. Verapamil enhances the inhibitory effect of diclofenac on the chemiluminescence of human polymorphonuclear leukocytes and carrageenan-induced rat's paw oedema. International Journal of Immunopharmacology 14: 83-91.
3. Abou-Mohamed, G., H.A. El-Kashef, H.A. Salem, et al. 1995. Effect of zinc on the anti-inflammatory and ulcerogenic activities of indometacin and diclofenac. Pharmacology 50: 266-272.
4. Mahgoub, A.A. 2002. Grapefruit juice potentiates the anti-inflammatory effects of diclofenac on the carrageenan-induced rat's paw oedema. Pharmacological Research 45: 1-4.
5. Al-Arfaj, A.S., A.A. Mustafa, S.R. Alballa, et al. 2003. Interaction of allopurinol and non-steroidal anti-inflammatory drugs on the carra-geenan-induced rat paw edema. Saudi Medical Journal 24: 936-940. (Pubitemid 37259001)
6. Al-Majed, A.A., M. Khattab, M. Raza, et al. 2003. Potentiation of diclofenac-induced anti-inflammatory response by aminoguanidine in carrageenan-induced acute inflammation in rats: the role of nitric oxide. Inflammation Research 52: 378-382. (Pubitemid 37130005)
7. Santos, L.H., C.A. Feres, F.H. Melo, et al. 2004. Anti-inflammatory, antinociceptive and ulcerogenic activity of a zinc-diclofenac complex in rats. Brazilian Journal of Medical and Biological Research 37: 1205-1213. (Pubitemid 39172555)
8. Tiwari, S.A., B.R. Daswani, S.S. Dabhade, et al. 2012. Interaction of diclofenac sodium and atorvastatin in rodent model of acute inflammation. Int J Pharm Biomed Res. 3: 167-171.
9. Sümen, G., M. Cimşit, and L. Eroglu. 2001. Hyperbaric oxygen treatment reduces carrageenan-induced acute inflammation in rats. European Journal of Pharmacology 431: 265-268.
10. Halici, Z., G.O. Dengiz, F. Odabasoglu, et al. 2007. Amiodarone has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced paw edema. European Journal of Pharmacology 566: 215-221. (Pubitemid 46805091)
11. Mohamed Saleem, T.S., S. Darbar Basha, G. Mahesh, et al. 2011. Analgesic, anti-pyretic and anti-inflammatory activity of dietary sesame oil in experimental animal models. Pharmacologia. 2: 172-177.
12. Epstein, O.I. 2012. Release-activity: a long way from the phenomenon to new drugs. Bulletin of Experimental Biology and Medicine 154: 54-58.
13. Epstein, O.I. 2008. Ultra-low doses (history of one study). Moscow, Russia: Publishing House of RAMN.
14. Epstein, O.I. 1999. Possible mechanisms of action of potentiated drugs and some of the questions of functioning of biosystems. Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences. 1: 132-149 (Russian).
15. Epstein, O., Vorob'eva, T., Berchenko, O., et al. 1997. Information and ontological models of adaptation. Moscow: IMPE [Monograph in Russian].
16. Epstein, O.I., T.A. Voronina, G.M. Molodavkin, et al. 2007. Study of bipathic effect of phenazepam. Bulletin of Experimental Biology and Medicine 144: 536-538. (Pubitemid 351279774)
17. Voronina, T.A., M.V. Belopolskaya, I.A. Kheyfets, et al. 2008. Study of bipathic effect of haloperidol. Bulletin of Experimental Biology and Medicine 145: 620-622.
18. Winter, C.A., E.A. Risley, and G.W. Nuss. 1962. Carrageenan induced oedema in hind paw of rat as assay for anti-inflammatory drugs. Proceedings of the Society for Experimental Biology and Medicine 111: 544-547.
19. Fernandes, J., H. Spindola, V. de Sousa, et al. 2010. Anti-inflammatory activity of chitooligosaccharides in vivo. Marine Drugs 8: 1763-1768.
20. Perianayagam, J.B., S.K. Sharma, and K.K. Pillai. 2006. Anti-inflammatory activity of Trichodesma indicium root extract in experimental animals. Journal of Ethnopharmacology 104: 410-414. (Pubitemid 43356654)
21. Purnima, A., B.C. Koti, A.H.M. Thippeswamy, et al. 2010. Evaluation of anti-in fl ammatory activity of Centratherum anthelminticum (L) kunze seed. Indian J Pharm Sci. 72: 697-703.
22. Sharma, S., K.S. Lakshmi, A. Patidar, et al. 2009. Studies on anti-inflammatory effect of aqueous extract of leaves of Holoptelea integrifolia, Planch in rats. Indian J Pharmacol 41: 87-88.
23. Raza, M., M.A.H. Dhariwal, A.M. Ageel, et al. 1996. Evaluation of the antiinflammatory activity of sodium valproate in rats and mice. General Pharmacology 27: 1395-1400. (Pubitemid 26419700)
24. Leyck, S., and M.J. Parnham. 1990. Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen. Agents and Actions 30: 426-431. (Pubitemid 20185154)
25. Gursoy, A., L. Eroglu, S. Ulutin, et al. 1989. Evaluation of indomethacin nanocapsules for their physical stability and inhibitory activity on inflammation and platelet aggregation. International Journal of Pharmaceutics 52: 101-108. (Pubitemid 19148789)
26. Otterness, I.G., E.H.Wiseman, and D. Gans. 1979. A comparison of the carrageenan edema test and the ultraviolet light-induced erythema test as predictors of the clinical dose in rheumatoid arthritis. Agents and Actions 9: 177-183. (Pubitemid 9203882)
27. Di Rosa, M., J.P. Giroud, and D.A.Willoughdy. 1971. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. The Journal of Pathology 104: 15-29.
28. Schweitzer, A., N. Hasler-Nguyen, and J. Zijlstra. 2009. Preferential uptake of the non steroid anti-inflammatory drug diclofenac into inflamed tissues after a single oraldose in rats. BMC Pharmacology 9: 5. doi:10.1186/1471-2210-9-5.
29. Kam, P.C., and A.U. See. 2000. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia 55: 442-449. (Pubitemid 30301443)
30. Vinegar, R., W. Schreiber, and R. Hugo. 1969. Biphasic development of carrageenan edema in rats. Journal of Pharmacology and Experimental Therapeutics 166: 96-103.
31. Vane, J.R. 1976. Prostaglandins as mediators of inflammation. Advances in Prostaglandin and Thromboxane Research 2: 791-801.
32. Futaki, N., S. Takahashi, M.Yokoyama, et al. 1994.NS-398, a newantiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47: 55-59. (Pubitemid 24053843)
33. Yang, H.W. 2009. COX-2 regulation of prostaglandins in synaptic signaling. Sheng Li Ke Xue Jin Zhan 40: 317-320.
34. Salvemini, D., Z. Wang, P.S. Wyatt, et al. 1996. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. British Journal of Pharmacology 118: 829-838. (Pubitemid 26261251)
35. Petrov, V.I., Kheyfets, I.A., Bugaeva, L.I., et al. 2011. Study of bipathy phenomenon of diclofenac acute toxicity. XVIII Russian National Congress "Man and Medicine". Book of abstracts. p. 470
36. Nicoll, J., E.A. Gorbunov, S.A. Tarasov, and O.I. Epstein. 2013. Subetta treatment increases adiponectin secretion by mature human adipocytes in vitro. International Journal of Endocrinology. doi:10.1155/2013/925874.
37. Standing, J.F., K. Ooi, S. Keady, et al. 2009. Prospective observational study of adverse drug reactions to diclofenac in children. British Journal of Clinical Pharmacology 68: 243-251.
38. Dahlberg, L.E., I. Holme, K. Høye, et al. 2009. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis. Scandinavian Journal of Rheumatology 38: 133-143.
39. Liaropoulos, L. 1999. Economic comparison of nimesulide and diclofenac, and the incidence of adverse events in the treatment of rheumatic disease in Greece. Rheumatology (Oxford, England) 38(Suppl 1): 39-46. (Pubitemid 29505042)
40. Banks, A.T., H.J. Zimmerman, K.G. Ishak, et al. 1995. Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 22: 820-827.